Intravitreal Ranibizumab Alone or in Combination with Calcium Dobesilate for the Treatment of Diabetic Macular Edema in Nonproliferative Diabetic Retinopathy Patients: 12-Month Outcomes of a Retrospective Study

Table 2

Changes of CMT and BCVA after the treatment.

	BCVA (logMAR)			CMT (μm)
	IVR (n = 48)	IVR + CaD (n = 54)	value	IVR (n = 48)	IVR + CaD (n = 54)	value
Baseline	0.35 ± 0.04	0.34 ± 0.04	0.416	428.21 ± 100.68	424.48 ± 88.42	0.843
At 3 month	0.24 ± 0.04	0.23 ± 0.04	0.253	288.27 ± 19.83	282.06 ± 26.55	0.188
At 6 month	0.26 ± 0.04	0.25 ± 0.04	0.436	281.40 ± 27.34	274.33 ± 31.74	0.234
At 12 month	0.25 ± 0.03	0.24 ± 0.04	0.696	269.33 ± 28.82	264.93 ± 27.16	0.429

represents when compared with the corresponding parameters at the baseline.